B
B

Dividends • Barinthus Biotherapeutics

BRNS

Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.

See below the complete and updated table with all dividends paid and declared history, etc

Excluding Date
Payment
Value ($)
Frequency
7/12/2024
7/26/2024
0,37
Quarterly
4/25/2024
5/7/2024
0,303
Quarterly
4/11/2024
4/26/2024
0,37
Quarterly
2/2/2024
2/15/2024
0,303
Quarterly
1/11/2024
1/26/2024
0,37
Quarterly
10/26/2023
11/7/2023
0,303
Quarterly
10/12/2023
10/27/2023
0,37
Quarterly
7/27/2023
8/8/2023
0,275
Quarterly
7/13/2023
7/28/2023
0,37
Quarterly
4/27/2023
5/9/2023
0,275
Quarterly
4/13/2023
4/28/2023
0,37
Quarterly
1/27/2023
2/10/2023
0,275
Quarterly
1/12/2023
1/27/2023
0,37
Quarterly